MDM2 and neoplasm: Xiao M. et al. (2010) found that genetic polymorphism of the TP53 gene was associated with risk of NPC. Hwang et al. (2009) suggested TP53 suppressed NPC tumor progression by regulating MDM2 mediated by NOLC1.